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Summary
The Eph family of receptor tyrosine kinases and their
ephrin ligands are mediators of cell-cell communica-
tion. Cleavage of ephrin-A2 by the ADAM10 mem-
brane metalloprotease enables contact repulsion be-
tween Eph- and ephrin-expressing cells. How ADAM10
interacts with ephrins in a regulated manner to cleave
only Eph bound ephrin molecules remains unclear.
The structure of ADAM10 disintegrin and cysteine-
rich domains and the functional studies presented
here define an essential substrate-recognition mod-
ule for functional interaction of ADAM10 with the
ephrin-A5/EphA3 complex. While ADAM10 constitu-
tively associates with EphA3, the formation of a func-
tional EphA3/ephrin-A5 complex creates a new molecu-
lar recognition motif for the ADAM10 cysteine-rich
domain that positions the proteinase domain for effec-
tive ephrin-A5 cleavage. Surprisingly, the cleavage
occurs in trans, with ADAM10 and its substrate being
on the membranes of opposing cells. Our data sug-
gest a simple mechanism for regulating ADAM10-
mediated ephrin proteolysis, which ensures that only
Eph bound ephrins are recognized and cleaved.
Introduction
The Eph receptors, the largest subfamily of receptor
tyrosine kinases (RTKs), and their ephrin ligands are im-
portant mediators of cell-cell communications regulat-
ing cell attachment, shape, and mobility (Poliakov et
al., 2004; Flanagan and Vanderhaeghen, 1998; Himanen
and Nikolov, 2003). Ephrin-Eph interactions between
opposing cells lead to bidirectional signaling and typi-
cally induce cell-cell repulsion. Based on their affinities
for each other and on sequence conservation, Ephs*Correspondence: nikolovd@mskcc.org (D.B.N.); martin.lackmann@
med.monash.edu.au (M.L.)
4 These authors contributed equally to this work.and ephrins are divided into two subclasses—A and B.
Upon cell-cell contact, the interacting Ephs and ephrins
form heterotetramers (Himanen et al., 2001), which are
further assembled in large signaling clusters (Wimmer-
Kleikamp et al., 2004). The resulting multivalent molec-
ular tethers between opposing cells must be broken to
enable cell repulsion and signal termination. Two gen-
eral mechanisms have been proposed that allow ter-
mination of Eph/ephrin-mediated cell contacts: the first
one involves rapid endocytosis of whole Eph/ephrin
complexes during the retraction of the interacting cells
or neuronal growth cones. For example, EphB4 binding
to ephrin-B2 is reported to induce separation of the in-
teracting cells, coincident with transendocytosis of the
complete high-affinity complex into either cell in a man-
ner that depends on the intracellular domains of the
molecules (Zimmer et al., 2003) and on Rac signaling
(Marston et al., 2003). The second proposed mecha-
nism involves regulated cleavage of the ephrin ligands
by transmembrane proteases following cell-cell con-
tact. For example, ephrin-B3 is a substrate for the
rhomboid transmembrane protease RHBDL2 (Pascall
and Brown, 2004), although the physiological relevance
of this cleavage is yet to be determined. For A-type
ephrins, only proteolytic shedding has been reported.
Thus, ephrin-A2 is cleaved by the metalloprotease
ADAM10 (A disintegrin and metalloprotease 10), a pro-
cess essential for disrupting Eph/ephrin cell contacts
in vivo (Hattori et al., 2000).
ADAM proteases are multidomain transmembrane
proteins, comprising extracellular protease, disintegrin,
cysteine-rich, and EGF-like domains (Blobel, 2005;
White, 2003). Surprisingly, these enzymes do not mani-
fest a typical cleavage sequence signature and sub-
strate specificity is not fully conveyed by the proteinase
domain but can also depend on the other noncatalytic
extracellular regions including the disintegrin and cys-
teine-rich domains (Reddy et al., 2000; Smith et al.,
2002; White, 2003). In the case of ephrin shedding,
ADAM10 was found to be constitutively associated with
ephrin-A2, and the presence of clustered EphA3 was
required for efficient cleavage. The ephrin cleavage was
proposed to occur in cis (within the same cell mem-
brane harboring both proteinase and substrate) as has
been documented so far for all other ADAM-mediated
shedding. While a peptide derived from a conserved
region within the Eph binding domain of ephrin-A2 ap-
peared to enhance cleavage and suggested a potential
ADAM/ephrin interaction interface (Hattori et al., 2000),
subsequently determined structures of two Eph/ephrin
complexes (Himanen et al., 2001, 2004) revealed the
corresponding ephrin region to be directly involved in
Eph binding and unavailable for ADAM interactions
upon Eph/ephrin complex formation. It still remains un-
clear how ADAM10 interacts with ephrins in a regulated
manner, ensuring cleavage of only Eph bound ephrin
molecules. We therefore decided to investigate the in-
teraction of ADAM10 with the complex between cell-
surface EphA3 and its high-affinity ligand ephrin-A5.
Cell
292Figure 1. EphA3-ADAM10 Association and Ephrin-A5 Cleavage
(A) Association of ADAM10 with EphA3 in LiBr melanoma cells and
parental or stably transfected EphA3/HEK293 cells. The cells were
treated with clustered ephrin-Fc (A5 or A2) or were left untreated
(−) prior to lysis. Anti-EphA3 immunoprecipitates from lysates were
analyzed by Western blot for endogenous ADAM10 (“p” and “m”
indicate the pro [unprocessed] and mature [processed] forms of
ADAM10). Aliquots from immunoprecipitates were blotted for
EphA3 levels to indicate loading (lower panel). Arrowheads “” in-
dicate lanes where the specificity of ADAM10 detection was veri-
fied by blocking of anti-ADAM10 antibodies during immunoblot
with recombinant ADAM10MP. Graphs show quantitation of coim-
munoprecipitated bands normalized for total EphA3 levels.
(B) EphA3, but not ephrin-A5, interacts with dominant-negative
ADAM10. EphA3/HEK293 or ephrin-A5/HEK293 cells were trans-
fected to express HA-tagged ADAM10MP. Western blots of anti-
HA immunoprecipitates were analyzed with antibodies against
ephrin-A5 and EphA3; parallel control samples were analyzed with
anti-ADAM10 antibodies. Lysates of ephrin-A5/HEK 293 cells were
also extracted with Protein-A-Sepharose bound EphA3-Fc and an-
alyzed with anti-ephrin-A5 antibodies. The control cells were trans-
fected with nonrelevant (eGFP-encoding) vector.
(C) Ephrin-A5 preclustering is required for metalloprotease-medi-
ated cleavage. EphA3/293 cells with (+) or without (−) exposure to
1,10-O-Phenanthroline (OPN, used at a concentration that main-
tains cell viability as assessed by trypan blue exclusion) were
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i004) ephrin-A5-Fc (Figures 2A, 2C–2F, and 2L). The
reated with clustered (c) or nonclustered (nc) ephrin-A5-Fc. Pooled
ell lysates (containing the majority of cleaved ephrin) and super-
atants were precleared with excess Protein-A-Sepharose; cleaved
phrin-A5 was extracted using EphA3-Fc coupled to Protein-
-Sepharose and analyzed by anti-ephrin-A5 immunoblot. Recom-
inant, monomeric, single-chain ephrin-A5 that had been cleaved
rom ephrin-A5 Fc (Himanen et al., 2004) (ephrin std) was analyzed
n parallel.e chose the EphA3/ephrin-A5 signaling system be-
ause ephrin-A2 and -A5 share very similar biological
unctions (Flanagan and Vanderhaeghen, 1998) and we
ave previously analyzed in detail the assembly of EphA3/
phrin-A5 signaling clusters (Himanen et al., 2004;
mith et al., 2004) and downstream cell-biological re-
ponses (Lawrenson et al., 2002).
esults
DAM10 Associates with EphA3 on the Cell Surface
nitially, we investigated whether ADAM10 interacts
ith either EphA3 or ephrin-A5 on the cell surface and
ow these interactions are affected upon Eph/ephrin
omplex formation. Endogenous ADAM10 coimmuno-
recipitated with EphA3 in cell lysates of stably EphA3-
ransfected HEK293 cells (EphA3/HEK293) and EphA3-
ositive LiBr melanoma cells (Lawrenson et al., 2002),
ut not in lysates of parental (untransfected) HEK293
ells (Figure 1A). Blocking of the anti-ADAM10 antibod-
es during immunoblot analysis, by preincubation with
ecombinant ADAM10MP (see Figure S1B in the Sup-
lemental Data available with this article online), re-
uced the ADAM10-associated bands to background
 in Figure 1A), confirming its specificity. Eph/ADAM10
oimmunoprecipitation was increased in cells that had
een exposed to preclustered ephrin-A5-Fc or ephrin-
2-Fc. EphA3 also coimmunoprecipitated with tran-
iently expressed, HA-tagged ADAM10 lacking the
etalloprotease domain (ADAM10MP—discussed in
attori et al. [2000]). By contrast, a parallel experiment
evealed that ADAM10MP did not interact with cell-sur-
ace ephrin-A5 in HEK293 cells stably expressing
phrin-A5 (ephrin-A5/HEK293) (Figure 1B; see also Fig-
re S1A).
DAM10 Cleaves Ephrin-A5 upon Binding to EphA3
hen cells expressing both ADAM10 and EphA3, such
s the EphA3/HEK293 cells discussed above, are ex-
osed to ephrin-A5-Fc, we observe cleavage of the fu-
ion protein to single-chain, Mr w 28k ephrin-A5. This
rocessing is notably elevated in cell cultures that has
een exposed to an excess of preclustered, as com-
ared to nonclustered, ephrin-A5-Fc (Figure 1C). Since
t has been well documented that Eph activation re-
uires cell contact with preclustered ligand (Poliakov
t al., 2004; Flanagan and Vanderhaeghen, 1998) this
bservation suggests that ephrin cleavage and Eph ac-
ivation are linked (Hattori et al., 2000).
We examined ephrin cleavage and internalization in
phA3/HEK293 cells that had been exposed to beads-
oated with Alexa546-labeled (Wimmer-Kleikamp et al.,
A Switch Regulating Ephrin Cleavage by ADAM10
293Figure 2. ADAM10 Mediates Ephrin Cleavage and Internalization
(A–H) Ephrin-A5 cleavage and internalization are inhibited by dominant-negative ADAM10 and metalloprotease inhibitors, or (I–N) by silencing
using ADAM10-specific siRNA. EphA3-overexpressing (EphA3/HEK293) cells (A and C–G), or parental HEK293 cells (B) were incubated
with Alexa546-labeled ephrin-A5-Fc beads (A–F) or Alexa546-Fc control beads (G). They were then fixed and analyzed for internalized
Alexa546ephrin-A5 by confocal microscopy. Cells were pretreated as follows: (A, B, and G) no pretreatment; (C) pretreatment with 1 mM OPN;
(D) pretreatment with 50 M TAPI1; (E and F) transient transfection with HA-ADAM10MP.
(F) The expression of dominant-negative ADAM10MP, assessed using anti-HA (α-HA) and Alexa488-conjugated secondary antibodies, is
illustrated in green. Arrowhead denotes a cell (outlined in [E] and [F] with a dotted line) expressing no detectable ADAM10MP and containing
internalized ephrin-A5. Scale bar: 10 m.
(H) The percentage of cells bound by beads that internalized ephrin-A5 is shown.
(I–L) EphA3/HEK293 cells, transiently transfected with ADAM10-specific siRNA (I and J), or with nonrelevant GFP siRNA (K and L), were
incubated with Alexa546-ephrin-A5-Fc beads. Ephrin internalization was assessed by confocal microscopy.
(I and K) Alexa488 images of cells stained with anti-ADAM10 mAb (α-ADAM) and Alexa488-labeled secondary antibodies to monitor ADAM10
expression; (J and L) Alexa546-fluorescence images to monitor cleaved, internalized ephrin-A5. Scale bar: 10 m.
(M) RT-PCR of RNA extracted from parallel cell cultures, verifying specific depletion of ADAM10 mRNA.
(N) The effect of ADAM10 silencing was estimated from counting Alexa546-containing cells in 10 randomly selected microscopic fields by a
“blinded” observer. The mean (black bars) and standard error (gray bars) for each condition are shown.metalloprotease inhibitors 1,10-O-Phenanthroline (OPN)
and TAPI (Figures 1C, 2C, and 2D) effectively inhibited
ephrin-A5 cleavage and internalization, consistent with
shedding being due to a metalloprotease such as
ADAM10. In agreement, exogenous expression of dom-
inant-negative ADAM10MP (Hattori et al., 2000) effec-
tively blocked ephrin cleavage and internalization,
while ephrin internalization progressed unhindered into
the cells that remained untransfected (Figures 2E and
2F; the arrowheads indicate a cell, which has undetect-
able expression of exogenous ADAM10MP).
To verify that ADAM10 is the only ADAM family mem-
ber responsible for ephrin cleavage, we silenced its ex-pression by transfecting the EphA3/HEK293 cells with
ADAM10-specific siRNA. As expected, loss of ADAM10
mRNA (Figure 2M) and ADAM10 protein expression
(Figure 2I) resulted in notably decreased ephrin shedding
and undetectable cytoplasmic (internalized) Alexa546-
labeled protein (Figure 2J). By contrast, control siRNA-
transfected cells, retaining visible ADAM10 cell-surface
expression (Figure 2K), revealed distinct pools of cyto-
plasmic Alexa546-labeled ephrin (Figure 2L). Taken to-
gether, the fluorescence microscopic analysis (Figures
2I–2L) indicates that specific ADAM10 protein down-
regulation potently inhibits cleavage and internalization
of ephrin-A5 into EphA3-expressing cells.
Cell
294Figure 3. Identification of the ADAM10, EphA3, and Ephrin-A5 Do-
mains that Mediate Their Interactions
(A) The EphA3 ligand binding domain is required for constitutive
and ephrin-A5-induced ADAM binding. HEK293 cells were trans-
fected with HA-ADAM10MP alone (control) or together with wt
EphA3 or EphA3 truncation mutants lacking the N-terminal ligand
binding domain (LBD) or the C-terminal PDZ binding domain
(PDZb). Anti-HA immunoprecipitates and total lysates from cells
treated with (+) crosslinked ephrin-A5-Fc or left untreated (−) and
were analyzed by Western blotting with the indicated antibodies.
(B) ADAM10D+C binding to various ephrins. Ephrin-Fc fusion pro-
teins were coincubated with ADAM10D+C; the ephrin-Fc bound
proteins were recovered on Protein-A-Sepharose and analyzed
by SDS-PAGE. The control lane (−) shows Protein-A bound
ADAM10D+C incubated alone. The two ADAM10 bands on Figures
3B–3D and 6A correspond to differently glycosylated forms of the
recombinant protein.
(C) ADAM10D+C binds the EphA3/ephrin-A5 complex but not the
individual proteins. EphA3-Fc, ephrin-A5, and ADAM10D+C were in-
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bnown to mediate protein-protein interactions regulat-
ubated together in various combinations (below), recovered on
rotein-A-Sepharose and analyzed by SDS-PAGE. Ephrin-A5-Fc
inding to ADAM10D+C was also tested in the absence of EphA3
lanes 9 and 10). Lane 1: MW markers. Lane 2: ADAM10D+C in-
ut (15g). Lanes 3–10: Protein-A-Sepharose pull downs; 3:
DAM10D+C; 4: EphA3-Fc; 5: ephrin-A5; 6: EphA3-Fc + ephrin-A5;
: ADAM10D+C + EphA3-Fc; 8: ADAM10D+C + EphA3-Fc + ephrin-
5; 9: ephrin-A5-Fc; 10: ADAM10D+C + ephrin-A5-Fc.
D) The ADAM10 cysteine-rich domain mediates the interaction
ith the EphA3/ephrin-A5 complex. Recombinant ADAM10 disin-
egrin (ADAM10(D); lanes 2–6) and cysteine-rich (ADAM10(C); lanes
–11) domains were incubated with EphA3 and/or ephrin-A5 (as
etailed below), and Protein-A bound proteins were analyzed as in
anels (A) and (B). Lanes 2 and 7: ADAM(D) and -(C) protein inputs;
anes 3 and 8: ADAM(D) and ADAM(C) constructs alone; or coincu-
ated with EphA3-Fc (4 and 9); with ephrin-A5-Fc (5 and 10); or
ith EphA3-Fc and ephrin-A5 (6 and 11); lane 12: ephrin-A5 incu-
ated with EphA3-Fc.phA3 Interacts with ADAM10 via Its Ligand
inding Domain
e next sought to identify the EphA3 region that pro-
ides the ADAM10 interaction interface. Wild-type (wt)
phA3 or EphA3 lacking the ligand binding domain
LBD, ephA3 exons I–III; Himanen and Nikolov, 2003;
ackmann et al., 1998) or parts of the cytoplasmic do-
ain were cotransfected together with ADAM10MP
nto HEK293 cells. The LBD-truncated EphA3 has pre-
iously been used in structure/function studies and is
xported effectively to the cell surface (Lackmann et
l., 1998). Both constitutive and ephrin-A5-enhanced
inding of ADAM10 was significantly reduced by dele-
ion of the ephrin binding domain of EphA3 (Figure 3A),
hile strong binding was retained in EphA3 mutants
acking either the C-terminal PDZ binding domain (Fig-
re 3A) or the whole cytoplasmic domain (data not
hown), in line with the notion that the EphA3 LBD pro-
ides the essential ADAM10-interacting interface. To
urther confirm that not merely the presence of EphA3,
ut specifically its binding to ephrin-A5, is required
or ADAM10-mediated ephrin cleavage, we compared
lexa546-ephrin-A5-Fc cleavage and internalization in
EK293 cells expressing either wt or ephrin binding-
ompromised EphA3-GFP (containing amino acid sub-
titutions F152L, V133E, and N232I; Smith et al., 2004).
he decreased (by 30%) ephrin-A5 cleavage in the cells
xpressing the ephrin binding-compromised EphA3
Figure S3) indicates that effective shedding relies on
he high-affinity Eph/ephrin interaction.
he ADAM10 Cys-Rich Domain Recognizes
he EphA3/Ephrin-A5 Complex but Not
he Individual Proteins
e next set out to determine which region of ADAM10
s responsible for its interaction with EphA3. ADAMs
ave a multidomain extracellular region (Figure 4A), in-
luding an N-terminal prosequence that is removed to
ctivate the adjacent protease domain, which is fol-
owed by a disintegrin, and a cysteine-rich domain (Blo-
el, 2000; Primakoff and Myles, 2000). While the prote-
se domain was previously shown not to be required
or the ADAM10-ephrin-A2 interactions (Hattori et al.,
000), the disintegrin and cysteine-rich domains are
A Switch Regulating Ephrin Cleavage by ADAM10
295Figure 4. Domain Organization and Sequence Alignment of ADAM Metalloproteases
(A) Schematic representation of ADAM proteinases protein domain organization.
(B) Structure-based sequence alignment of the disintegrin and Cys-rich region of various ADAMs. ADAM10 as well as the related ADAM17
and an ADAM from Schizosaccharomyces pombe (presumably the founding member of this protein family in evolutionary terms) are aligned
in the top three lines, whereas ADAMs 9, 12, and 15 are shown in the bottom three lines. The spacing of cysteine residues is highly conserved
among all ADAMs through Cys572. From that point onward, there is a clear divergence in the cysteine spacing, with ADAMs 10 and 17 as
well as the S. pombe ADAM having a conserved cysteine-rich region, which differs from the equally conserved cysteine-rich region of all
other mammalian ADAMs. Moreover, ADAMs10 and 17 as well as the S. pombe ADAM lack a membrane proximal EGF repeat, which is
present in all other ADAMs (indicated by a black line over the sequence of ADAMs 9, 12, and 15). Secondary structure elements (disintegrin
domain: yellow; Cys-rich domain: green) are indicated above the alignment. Conserved cysteines are in blue. The red and the gray dots mark
the locations of the [EEE-A] and [RDD-A] mutations discussed in the text.
(C) The phylogenetic relationship of the ectodomains of selected mammalian ADAMs and the ADAM from Schizosaccharomyces pombe,
determined using the DNA Star Clustal alignment program.ing cell adhesion and ADAM protease specificity (Reddy
et al., 2000; Smith et al., 2002; White, 2003). We therefore
used a recombinant construct containing these twodomains, ADAM10D+C (residues 455–646), to carry out
in vitro binding experiments.
In agreement with previous findings (Hattori et al.,
Cell
2962000; see also Figure S4), ADAM10D+C bound to ephrin-
A2, as well as to ephrin-A1, but not to ephrin-A5 or
any other tested ephrins (Figure 3B). Likewise, it did not
interact with the ectodomain of EphA3 (Figure 3C) or
any of the other Ephs tested (EphA2, -A4, -B1, -B2; data
not shown). However, ADAM10D+C readily bound and
formed a stable ternary complex when incubated
simultaneously with both EphA3 and ephrin-A5. It is
noteworthy that the amount of EphA3 bound ephrin-A5
increases in the presence of ADAM10D+C (Figure 3C,
lanes 6 and 8; see also Figures 3D and 6A), suggesting
that ADAM binding stabilizes the EphA3/ephrin-A5 in-
teraction. To determine whether the substrate-interac-
tion surface is part of the cysteine-rich domain, the dis-
integrin domain, or both, we performed in vitro binding
assays with the individual recombinant domains. These
revealed that binding to the EphA3/ephrin-A5 complex
is mediated by the cysteine-rich domain (Figure 3D,
lane 11).
Structure of the ADAM10
Substrate-Recognition Module
To gain insights into the molecular architecture of the
ADAM10 region mediating the Eph/ephrin interaction,
we determined the ADAM10D+C structure at 2.9 Å reso-
lution and an R factor of 26.1 (Rfree of 28.9%; Table S1).
The disintegrin and Cys-rich domains (Figure 4) fold in
a continuous elongated, slightly curved structure ex-
tending approximately 75 Å (Figure 5A). The secondary
structure content is relatively low, with just two β
strands in the disintegrin domain (yellow on Figure 5A)
and seven short β strands and 3 short α helices in the
Cys-rich domain (green on Figure 5A). Apart from small
hydrophobic cores in the Cys-rich domain and at the
interface between the two domains, the overall struc-
ture is mainly stabilized by a series of disulfide bonds
involving all of the cysteine residues within the refined
model.
The ADAM Disintegrin Domain Is Structurally Similar
to the Snake Venom Disintegrins
A survey of the FSSP structure database (Holm and
Sander, 1998) reveals structural homology of the ADAM10
disintegrin domain with the disintegrins trimestatin (1j2l
[Fujii et al., 2003]) and the blood coagulation inhibitor
(1fvl [Senn and Klaus, 1993]), while the ADAM10 Cys-
rich domain has a new and unique fold. Both trimestatin
and the blood coagulation inhibitor are intermediate
sized, or class II, disintegrins containing approximately
70 residues and 12 conserved cysteines.
The ADAM10 disintegrin domain spans residues 455–
550, whereby the N-terminal w40 residues are disor-
dered in the structure. The disulfide bonds of the
ADAM10 disintegrin domain are topologically identical
to the ones in trimestatin, including Cys484-Cys515,
Cys503-Cys511, Cys510-Cys536, and Cys524-Cys543.
Indeed, the disintegrin domain of ADAM10 can be su-
perimposed onto the disintegrin domains of trimestatin
and the blood coagulation inhibitor with root-mean-
square deviations between α-carbon positions of 1.4
and 1.9 Å respectively, for 50 directly equivalent resi-
dues sharing approximately 30% sequence identity
(Figure 5B). While it had been speculated that the
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GDAM10 disintegrin domain might be structurally dis-
inct from the distantly related snake venom disinteg-
ins, our structure documents that this is not the case.
ndeed, the structural similarity between these protein
amilies is a remarkable example of divergent evolution
f a conserved structural motif to perform novel and
istinct molecular functions.
he ADAM10 Cysteine-Rich Domain
as a Novel / Fold
he larger ADAM10 cysteine-rich domain (residues
51–646) packs against the disintegrin domain via a
ini hydrophobic core forming a continuous structure
hat suggests little interdomain flexibility. A disulfide
ridge (Cys530-Cys562) between the two domains fur-
her stabilizes their interaction and renders Cys530 un-
vailable for potential protein-protein interactions. In-
eed, Cys530 is conserved only in the disintegrin
omains of ADAMs and class III snake venom metallo-
roteases (which are always followed by a Cys-rich do-
ain), while in most snake venom disintegrins this posi-
ion is a part of the RGD sequence containing an
ntegrin binding site (integrin binding loop). The Cys-
ich domain has a novel α/β fold stabilized by five disul-
ide bonds: Cys555-Cys567, Cys572-Cys598, Cys580-
ys607, Cys597-Cys582, and Cys594-Cys639. The largest
f its three β sheets is composed of the three central β
trands that pack against the three α helices, while the
maller ones are composed of the two N-terminal and
he two C-terminal β strands, respectively. The N-ter-
inal β sheet packs against the first α helix of the cys-
eine-rich domain on one side and against the disinteg-
in domain on the other.
As illustrated in the alignment in Figure 4B, the spac-
ng of the conserved cysteine residues in the Cys-rich
omain of ADAM10 is very similar to that of ADAM17
nd of the only ADAM found in Scizosaccharomyces
ombe, which is most likely the first ADAM to have
volved (see Figure 4C). Interestingly, the spacing be-
ween the cysteine residues in all other mammalian
DAMs, including ADAMs 9, 12, and 15, differs in the
-terminal part of the Cys-rich domain, yet is also highly
onserved amongst the remaining ADAMs. Therefore, the
tructure of the Cys-rich domain of ADAM10, 17, and the
. pombe ADAM is likely to differ in its carboxy-terminal
egion from that of the other ADAMs. Moreover, all other
ammalian ADAMs, besides ADAM10 and ADAM17,
ave an EGF module between the Cys-rich domain and
he transmembrane region, while the ADAM10 Cys-rich
omain is separated from the cell membrane by only
6 residues, which are likely to be disordered.
n Acidic Surface Pocket in the ADAM10 Cys-Rich
omain Serves as Substrate-Recognition Site
he elongated form of ADAM10D+C provides an exten-
ive molecular surface (9800 Å2) for potential interactions
ith other proteins, such as ADAM substrates. Interest-
ngly, despite an overall neutral charge of ADAM10D+C,
relatively large negatively charged pocket dominates
ne side of the Cys-rich domain (Figure 5C). The local
egative electrostatic potential results from the proxim-
ty of several solvent-exposed acidic residues, including
lu573 and Glu578 at the entrance and Glu579 inside
A Switch Regulating Ephrin Cleavage by ADAM10
297Figure 5. Structure of the ADAM10 Disinteg-
rin and Cysteine-Rich Domains
(A) Stereoview of the ADAM10D+C structure.
The N and C termini are indicated.
(B) Stereoview of the ADAM10D+C structure
(disintegrin domain: yellow; Cys-rich domain:
green) superimposed on the structure of the
disintegrin trimestatin (1j2l [Fujii et al., 2003];
colored in blue).
(C) The molecular surface of ADAM10D+C
color-coded according to surface electro-
static potential; two 180°-rotated views are
shown. Red and blue represent electrostatic
potentials in the range of −12 (red) to +12
kBT (blue), where kB is the Boltzman con-
stant and T is the temperature (293 K).
(D) Close-up view of the acidic pocket show-
ing the three Glu residues targeted by muta-
genesis.the cavity (Figure 5D). Several hydrophobic residues,
both at the entrance (Phe635, Pro628, Pro631) and li-
ning the bottom of the pocket (Val596, Leu626), provide
additional indications that this structure might repre-
sent a protein-interaction interface.
To investigate whether this conspicuous pocket in-
deed represents the substrate binding site, we changed
the local surface electrostatic potential by replacing
Glu573, Glu578, and Glu579 with neutral alanines
(ADAM10 [EEE-A]). As a control, we mutated in aD+Csimilar fashion an RDD-like sequence within the so-
called “integrin binding loop” of the disintegrin domain
(ADAM10D+C[RDD-A]). We note, however, that there is
no evidence that ADAM10 binds integrins and that the
position of this RDD sequence is shifted compared
to the integrin binding disintegrins (Fujii et al., 2003;
Primakoff and Myles, 2000). In vitro binding analysis
(Figure 6A) revealed that the ADAM10D+C[EEE-A] sub-
stitution abrogates binding to the EphA3/ephrin-A5
complex, whereas ADAM10 [RDD-A] retains bindingD+C
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(A) In vitro binding of mutant ADAM10D+C to EphA3/ephrin-A5. ADAM10D+C[EEE-A] containing alanine substitutions of Glu573, Glu578, Glu579
(lanes 1–4) or ADAM10D+C[RDD-A] (Ala substitutions of Arg525, Asp526, Asp527, lanes 5–8) were incubated alone (lanes 1 and 5), or together
with EphA3-Fc (lanes 2 and 6), ephrin-A5-Fc (lanes 3 and 7), or EphA3-Fc + ephrin-A5 (lanes 4 and 8). Bound proteins were extracted with
Protein-A-Sepharose beads and analyzed as in Figures 3C and 3D.
A Switch Regulating Ephrin Cleavage by ADAM10
299ADAM10[EEE-A/K] to compete with the endogenous
(B) Binding of ADAM10MP and mutant ADAM10MP to EphA3 in cells. EphA3/HEK293 cells were transfected with HA-ADAM10MP or HA-
ADAM10MP[EEE-A]. Parental and transfected cells were treated with preclustered (c) or nonclustered (nc), ephrin-A5-Fc for 10 min prior to
lysis. Anti-HA and anti-EphA3 immunoprecipitates and total cell lysates were analyzed by Western blotting with indicated antibodies. Graphs
show quantitation of coimmunoprecipitated bands normalized for total EphA3 levels.
(C) Ephrin-A5-Fc cleavage on cells expressing wild-type and mutated ADAM10. EphA3/293 cells were left untransfected (control) or were
transfected with full-length, wild-type (wt) ADAM10, dominant-negative ADAM10MP, or ADAM10 bearing alanine (3A) or lysine (3K) substitu-
tions of Glu573, Glu578, and Glu579. Following exposure to clustered (c) or nonclustered (nc) ephrin-A5 Fc, cleaved ephrin was recovered and
analyzed by Western blot as described in Figure 1C. Soluble, monomeric ephrin-A5 (sol.ephr) was analyzed in a parallel sample as control.
Parallel anti-HA blots of whole-cell lysates reveal the expression levels of ADAM10 constructs. Quantitation of the recovered cleaved ephrin
is shown.
(D) The acidic pocket within the ADAM10 Cys-rich domain mediates cleavage of both ephrin-A5 and ephrin-A2 from opposing cells. HEK293
cells were cotransfected with EphA3-diHcRed and either wt ADAM10, ADAM10 bearing alanine (3A) substitutions at Glu573, Glu578, and Glu579,
or dominant-negative ADAM10MP. These were then coincubated with HEK293 cells expressing GFP-ephrin-A5 or GFP-ephrin-A2 for 40 min,
fixed, and stained with anti-HA antibodies. Individual confocal images of GFP-ephrin-expressing cells (green), EphA3-diHcRed-expressing
cells (red), anti-HA-ADAM10-staining (Alexa647, blue), as well as merged images, are shown as indicated. Arrowheads indicate cleaved and
internalized ephrin; arrows indicate ephrin aggregates at interacting cell surfaces. The percentage of EphA3- and HA-ADAM10-expressing
HEK293 cells in contact with ephrin/HEK293 cells that internalized ephrin is shown in the right panel.
(Figure S4A). In contrast, every other ADAM-mediatedcapacity for this ADAM substrate. Both mutations af-
fect neither binding to ephrin-A1 or -A2 (data not
shown) nor the overall fold and stability of the mutant
ADAM10D+C proteins which, apart from their distinct
binding characteristics for the EphA3/ephrin-A5 com-
plex, are biochemically undistinguishable from wild-
type ADAM10D+C.
To assess the relevance of the newly identified sub-
strate recognition pocket in the context of cell-surface-
expressed ADAM10, we introduced the [EEE-A] amino
acid substitutions into ADAM10MP. Not surprisingly,
coimmunoprecipitation of EphA3 and ADAM10 using
either anti-EphA3 (Figure 6B, top panels) or anti-HA an-
tibodies (to immunoprecipitate HA-tagged ADAM) (Fig-
ure 6B, bottom panels) revealed a significantly de-
creased interaction of mutant ADAM10MP[EEE-A] with
the EphA3/ephrin-A5 complex (compare lanes 4 and 6,
Figure 6B), whereas the constitutive association with
EphA3 remained unchanged (compare lanes 3 and 5,
Figure 6B). Together, these results strongly suggest that
the negatively-charged pocket within the Cys-rich do-
main of ADAM10 mediates the recognition and bind-
ing to the EphA3/ephrin-A5 complex, while a second
EphA3-interaction site outside the ADAM10 Cys-rich
domain mediates the weaker, constitutive association
with unligated EphA3.
We further evaluated the functional role of the ADAM
substrate recognition pocket by introducing the Glu573,
Glu578, and Glu579 substitutions into full-length ADAM10.
EphA3/HEK293 cells transiently overexpressing wild-
type ADAM10, mutant ADAM10: [EEE-A] or [EEE-K], or
catalytically-inactive ADAM10MP were treated with
nonclustered or preclustered ephrin-A5-Fc, and the
cleaved ephrin-A5 was extracted from the cell cultures.
Overexpression of ADAM10 mutants, either harboring
Ala (3A) or Lys (3K) substitutions of the three Glu resi-
dues or lacking the protease domain (MP), substan-
tially reduced or abrogated ephrin-A5 cleavage (Figure
6C), suggesting that shedding of cell-surface ephrin-A5
relies on the intact recognition pocket of ADAM10. Inter-
estingly, the [EEE-A/K] ADAM mutants act as dominant-
negative ADAM10 inhibitors. This is likely due to the
fact that the localized amino acid substitutions leave
the constitutive (ephrin-independent) EphA3/ADAM10
association intact, thus allowing the cleavage-deficientADAM10 for EphA3 binding and recruitment into the
Eph/ephrin clusters. Notably, overexpression of wt-
ADAM10 (wt) did not increase ephrin cleavage above
control levels, in line with the notion that cell-surface
EphA3, and thus the amount of ephrin-A5 involved in
active EphA3/ephrin-A5 signaling complexes, is rate
limiting for the cleavage reaction.
To examine the physiological relevance of the sub-
strate-recognition site for ADAM function in intact cells,
we performed confocal imaging of HEK293 cells trans-
fected to express diHcRed-tagged EphA3, which were
cocultured with cells expressing GFP-tagged ephrin-A5
or GFP-tagged ephrin-A2 (Hattori et al., 2000; Wimmer-
Kleikamp et al., 2004; Figure 6D). The appearance of
punctate ephrin-specific staining within the EphA3-
expressing cells is indicative of effective ephrin cleav-
age and subsequent internalization. To confirm the
expression of the HA-tagged, wt, or [EEE-A] mutant
ADAM10, the transfected, diHcRed-EphA3/HEK293
cells were stained with anti-HA and Alexa647-labeled
secondary antibodies, revealing a purple merged image
of cells coexpressing both proteins. Ephrin internaliza-
tion is readily noticeable in wt ADAM10-expressing
cells (Figure 6D, white arrow heads) but is absent in
cells expressing the ADAM10[EEE-A] mutant. In stark
contrast, the latter cells are discernible by the appear-
ance of distinct, dense cell-surface clusters of un-
cleaved and noninternalized GFP-ephrin at the points
of contact between Eph- and ephrin-expressing cells
(arrows in Figure 6D). Taken together, these experi-
ments demonstrate the role of the acidic pocket within
the ADAM10 Cys-rich domain to mediate an interaction
with the EphA3-ephrin-A5/A2 substrate that is essential
for ephrin cleavage from the cell surface.
ADAM10 Cleaves Ephrins In trans from the Surface
of the Opposing Cell
To this point our experiments suggest ADAM10-medi-
ated ephrin cleavage in trans (Figure 7A). In particular,
coexpression of ADAM10 with EphA3 promotes cleav-
age of ephrin-A5 immobilized to the surface of inter-
acting beads (Figure 1C), whereas coexpression of
ADAM10 with ephrin-A5 does not promote ephrin cleav-
age, even in the presence of preclustered EphA3-Fc
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(A) Schematic representation of the proposed interactions and positioning of ADAM10, EphA3, and ephrin-A5 between interacting cells,
leading to controlled ephrin cleavage.
(B) ADAM10 downregulation in Eph-expressing cells, but not in ephrin-expressing cells, blocks internalization of ephrin-A5 and ephrin-A2.
A Switch Regulating Ephrin Cleavage by ADAM10
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Cells expressing GFP-tagged ephrin-A5 or ephrin-A2 were coincubated with cells expressing EphA3-diHcRed, where either the Eph-express-
ing cells or the ephrin-expressing cells had been pretreated with control or ADAM10-specific siRNAs as indicated. After 40 min the cells were
washed, fixed, and analyzed for GFP-ephrin internalization into the EphA3 cells. Individual and merged confocal images of GFP-ephrin (green)
and EphA3-diHcRed (red) are shown as indicated. Arrowheads indicate cleaved and internalized ephrin; arrows indicate uncleaved ephrin
aggregates at interacting cell surfaces.
(C) Western blot analysis of siRNA-downregulation of ADAM10 protein in HEK293 cells. ADAM immunoprecipitates from HEK293 cells treated
with ADAM-specific and control siRNAs were Western blotted for ADAM10 expression (“p” and “m” indicate the pro and mature forms of
ADAM10). Expression of EphA3 and actin was also assessed in the same cell lysates as controls.
(D) The fraction of EphA3/293 cells in contact with ephrin/293 cells that internalized ephrin is quantitated for each experiment. Data from
control- or ADAM10-siRNA-treated EphA3-expressing cells are indicated in black bars; those with siRNA-treated ephrin-expressing cells are
in red bars.
(E) ADAM10-mediated cleavage of untagged ephrin-A5 expressed on opposing cells. EphA3/HEK293 cells were incubated under gentle
agitation with ephrin-A5/HEK293 cells, where either cell line had been transfected with ADAM10MP as indicated. Nonadherent cells were
aspirated and proteins of interest in adherent cells stained with appropriate antibodies and secondary, Alexa-conjugated antibodies against
the following: ephrin-A5 (anti-ephrin polyclonal antibody, Alexa546 anti-goat, red), EphA3 (IIIA4 monoclonal antibody [Smith et al., 2004],
Alexa647anti-mouse, blue) and ADAM10MP (anti-HA, Alexa488 anti-rat, green). Individual confocal images of ephrin-A5/HEK293 cells (Alexa546,
red, white stars), ADAM10MP-transfected (Alexa488, green, empty white arrow heads) and nontransfected (filled white arrow heads) EphA3/
HEK293 cells, and ADAM10MP (Alexa488, green, white arrows) expressing ephrin-A5/HEK293 cells, their merged images, as well as images
of the combined sections of all focal planes (Z stack, see Figure S5A) are shown as indicated.
ADAM10-mediated ephrin-A5 proteolysis, which en-protein ectodomain shedding has been documented
only to occur in cis (Blobel, 2000, 2005).
To validate the notion that ADAM10 acts on ephrin-
A5 and -A2 (when in complex with EphA3) in a non-cell-
autonomous (in trans) rather than a cell-autonomous (in
cis) fashion with respect to ephrin cleavage, we used
confocal microscopy to study interacting HEK293 cells
expressing either diHcRed-conjugated EphA3, GFP-
tagged ephrin-A5, or GFP-tagged ephrin-A2 (Figure 7B;
Hattori et al., 2000; Wimmer-Kleikamp et al., 2004).
Ephrin cleavage and internalization was discerned again
by the appearance of punctate, ephrin-specific green
fluorescence within the diHcRed-EphA3-expressing cells
(although in some fields the internalized ephrin appears
yellow—Figure 7B, arrowheads—due to colocalization
of GFP-ephrin with diHC-Red EphA3 during endocyto-
sis). As illustrated in Figure 7B, siRNA-mediated loss of
ADAM10 function in the EphA3-expressing cells effec-
tively abrogated cleavage and internalization of both
ephrin-A5 and ephrin-A2. Instead, the unprocessed
Eph/ephrin complexes assembled into conspicuously
dense, large clusters appearing as striking demarca-
tion of cell boundaries (arrows in Figure 7B). By con-
trast, siRNA-mediated loss of ADAM10 activity in the
ephrin-expressing cells had no effect on ephrin cleav-
age and internalization into the EphA3-expressing cells
(Figure 7D).
To confirm the concept of ADAM10-mediated ephrin-
shedding occurring exclusively in trans, we performed
ephrin-A5 cleavage experiments with wild-type, un-
tagged EphA3 and ephrin-A5, assessing at the same
time whether the function of the interacting proteins
was affected by the presence of the relatively large GFP
(or diHcRed) fluorescent tags used in the previous ex-
periments. To monitor ADAM10-mediated ephrin shed-
ding during cell-cell interactions, we added ephrin-A5/
HEK293 cells to monolayer cultures of EphA3/HEK293
cells (Figure S5B), whereby either cell type was trans-
fected in parallel experiments with dominant-negative
HA-ADAM10MP to block ADAM activity (Figure 7E). To
prevent spreading of the ephrin-A5-expressing cells
during the experiment and therefore aid their identifica-
tion, incubation was performed under gentle agitation,
leading to distinctively rounded ephrin-A5-expressingHA-ADAM10MP-transfectedEphA3/HEK293 cells (green
cell surface, Figure 7E top; merged images, w40% of
total population), do not notably internalize ephrin-
A5, even in cases where the interacting ephrin-A5-
expressing cells remained attached (Figure 7E, *),
whereas adjacent, untransfected EphA3/HEK293 cells
did (blue-purple cell surface; filled arrow heads). This is
particularly apparent when comparing several optical
(confocal) planes of the same section (Figure S5C). In
the parallel experiment (Figure 7E, bottom panels),
where an EphA3/HEK293 monolayer was incubated
with ADAM10MP-transfected ephrin-A5/HEK293 cells
(w70% ADAM10MP-positive; arrows, Figure 7E), all
EphA3-expressing cells internalized the immunoreac-
tive ephrin-A5 cleaved from the surface of the interact-
ing cell. Together, these experiments demonstrate that
the dominant-negative ADAM10MP inhibits ephrin cleav-
age only when expressed on the EphA3 cells, in trans
of the ephrin-A substrate. They, therefore, confirm the
hypothesis that the functional ADAM10 responsible for
the ephrin-A5 cleavage is the one located on the
EphA3-expressing cells, in line with the ADAM/Eph/
ephrin configuration presented on Figure 7A.
Discussion
The elucidation of the structure of the ADAM10 disin-
tegrin and cysteine-rich domains, together with the
comprehensive functional and mutagenesis studies
presented here, define a substrate-recognition module
that is essential for functional association of ADAM10
with the ephrin-A5/EphA3 complex and subsequent re-
positioning of the proteinase domain to allow effective
substrate cleavage in trans. The location of the module
within the cysteine-rich domain is consistent with previ-
ous findings of this domain controlling specificity of
certain ADAM proteolytic functions (Reddy et al., 2000;
Smith et al., 2002). The surface-exposed residues in
this region, including the three glutamic acids that are
essential for Eph/ephrin recognition, are highly diver-
gent, consistent with the diverse substrate preferences
of the different ADAM family members.
Our data suggest a simple mechanism for regulating
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302sures that only Eph-bound ephrins are recognized and
cleaved to allow their internalization into the Eph-
expressing cell: (1) prior to cell-cell contact, ADAM10 is
constitutively associated with EphA3 to ensure its close
proximity to potential substrates. It remains possible
that in certain cases ubiquitously expressed ADAM10
is recruited to the Eph/ephrin complex via constitutive
ephrin interactions, as was suggested for ephrin-A2
(Hattori et al., 2000). Our structure-based mutagenesis
indicates that constitutive EphA3-ADAM10 binding oc-
curs through an additional interface outside the acidic
substrate binding pocket but still involving the EphA3
ligand binding region. (2) Cell-cell contact-dependent
high-affinity EphA3/ephrin-A5 complexes present a
new recognition surface for ADAM10, which binds via
the substrate-recognition pocket in the Cys-rich do-
main. (3) The disintegrin domain, forming a continuous,
rigid structure with the cysteine-rich domain, positions
the adjacent N-terminal proteinase domain for effective
cleavage of its target–the stem region of ephrin-A5. (4)
The ensuing proteolytic cleavage of ephrin-A5 breaks
the molecular tethers between the opposing cell sur-
faces, allowing for signal termination and for internal-
ization of the EphA3/ephrin-A5 complexes into the Eph-
expressing cell.
It is also possible that binding of the Cys-rich domain
to the Eph/ephrin substrate serves to remove a putative
inhibitory interaction between ADAM10D+C and the pro-
teinase domain. Previous studies indeed suggest an in-
teraction between the ADAM catalytic domain with the
disintegrin domain and/or the cysteine-rich region
(Milla et al., 1999; Blobel, 2005). Another intriguing pos-
sibility is that the binding to the Eph/ephrin complex
disrupts an interaction between the ADAM metallopro-
teinase and cysteine-rich domains that is not inhibitory
but rather serves the purpose of keeping the active site
of the enzyme close to the cell surface on the ADAM-
expressing cell (the Cys-rich domain is membrane
proximal)—facilitating substrate cleavage, which usu-
ally occurs in cis. Disruption of such intramolecular
ADAM interaction would free the proteinase domain to
reach across to the opposing cell membrane and effect
cleavage in trans.
It seems likely that substrate-ADAM10D+C region in-
teractions specify the cleavage of other ephrins or even
shedding of growth factors such as the Notch ligand
Delta (Qi et al., 1999). However, in this context it should
be noted that the effect of Drosophila KUZ, which is
considered to be an ortholog of ADAM10, is cell auton-
omous with respect to activation of Notch, and there-
fore it presumably cleaves Notch in cis, at least during
development of sensory bristles (Rooke et al., 1996). In
the case of ephrin-A2, while the presence of an Eph
receptor is not required for the observed constitutive
ADAM/ephrin-A2 association (Hattori et al., 2000; Fig-
ure 3B), EphA3 does stimulate cleavage. Furthermore,
this cleavage is inhibited by mutations in the substrate
binding ADAM10 pocket (Figure 6D), suggesting that,
as with ephrin-A5, proteolysis is triggered by a protein-
ase-substrate conformational rearrangement dependent
on ephrin/Eph complex formation. Thus, substrate re-
cognition by the ADAM disintegrin/Cys-rich region,
rather than the proteinase domain, could be an impor-
tant component in the regulated (signal-induced) cleav-
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ase for the EphA3/ephrin complexes.
Importantly, the observed constitutive ADAM10-
phA3 interaction suggests that the functional ADAM10
s located on the cells that express the Eph receptor,
hile the ephrin substrate is located on the opposite
ells (Figure 7A). Our confocal microscopy experiments
rovide further compelling evidence that ephrin-cleav-
ge can only occur if functional ADAM10 is present in
rans of the ephrin substrate on the surface of the in-
eracting EphA3 expressing cells. While the possibility
hat ADAMs could function in trans has been previously
uggested (Blobel, 1997), to the best of our knowledge
he results reported here represent the first clear exper-
mental evidence for this.
xperimental Procedures
xpression Constructs
he sequence encoding bovine ADAM10 (Howard et al., 1996) dis-
ntegrin and cysteine-rich domains (residues 455–646) was sub-
loned as Fc fusion into pcDNA3.1 vector (Invitrogen), including
n N-terminal prolactin signal sequence and a C-terminal thrombin
leavage site followed by the Fc domain of human IgG, for expres-
ion in human embryonic kidney 293 (HEK293) cells. Following ini-
ial purification on a Protein-A-Sepharose (Amersham) column, the
c tag was removed by thrombin cleavage, and ADAM10D+C was
urther purified to homogeneity by gel filtration chromatography.
he two ADAM10D+C bands on the SDS gels correspond to dif-
erently glycosylated forms of the recombinant protein and con-
erge to a single band upon enzymatic deglycosylation. Point mu-
ations, as well as ADAM10 constructs encompassing only the
isintegrin domain (residues 455–570) and the cysteine-rich do-
ain (residues 551–646), were generated by PCR and expressed
sing the same expression vector.
Mutations into ADAM10D+C, ADAM10DMP-HA (Hattori et al.,
000), and wild-type ADAM10 (Howard et al., 1996) were intro-
uced by site-directed mutagenesis (Quickchange XL, Stratagene).
phA3 ectodomain deletion mutants were produced by ligating sol-
ble ectodomain mutants (Lackmann et al., 1998) to EphA3 trans-
embrane and cytoplasmic domains; EphA3cyto and PDZb
onstructs were produced by introduction of stop codons at Y570
nd K997, respectively. Ephrin-A5 and EphA3 ectodomain-Fc-fusion
roteins were produced as described (Wimmer-Kleikamp et al.,
004). Myc-tagged ephrin-A5 and GFP-ephrin-A5 were con-
tructed based on published ephrin-A2 constructs (Hattori et al.,
000). EphA3-diHcRed was constructed by substitution of the GFP
n EphA3-GFP (Wimmer-Kleikamp et al., 2004) with a tandem re-
eat of HcRed (Rocks et al., 2005).
DAM10 Knockdown by RNA Interference
phA3/HEK293 cells were transfected using Lipofectamine 2000
Invitrogen) with ADAM10-specific siRNA duplexes 5#-UGGGC
AUGUGCAGGUUCUTT-3# (SKI-RSI-7722, Sloan Kettering Cancer
entre HTS core facility) or a mix of 5#-AAUGAAGAGGGACACUU
CCUdTdT-3# and 5#-AAGUUGCCUCCUCCUAAACCAdTdT-3# (Fi-
cher et al., 2004) at 40 nM for 48 hr prior to analysis. Parallel
ell cultures were transfected with a control siRNA at the same
oncentration. Specific ADAM10 silencing was confirmed by RT-
CR analysis (Figure 2M) as described (Fischer et al., 2004), by
taining of cells with an anti-ADAM10 mouse monoclonal antibody
R&D Systems; Figures 2I and 2K), and by anti-ADAM Western blot
f ADAM10 immunoprecipitates (Figure 7C).
ell Manipulations, Immunoprecipitation,
estern Blotting, and Microscopy
ells in DME/10%FCS were transfected with Lipofectamine 2000
Invitrogen) and in some experiments treated with the metallopro-
ease inhibitors 1,10-O-Phenanthroline (OPN, 4 hr, 1 mM; Mumm et
l., 2000) and TAPI1 (1hr, 50 M; Yan et al., 2002), at which concen-
rations cell viability was maintained (as assessed by trypan blue
A Switch Regulating Ephrin Cleavage by ADAM10
303exclusion). HEK293 cells stably transfected with EphA3 or ephrin-
A5 have been described previously (Wimmer-Kleikamp et al., 2004).
Serum-starved cells were stimulated (10 min) with 1.5 g/ml pre-
clustered ephrin-A5-Fc, harvested, lysed in the presence of 1% Tri-
ton and 0.2% SDS (Hattori et al., 2000) and immunoprecipitated
with anti-EphA3 mAb IIIA4 (Smith et al., 2004), or anti-HA mAb
(Roche) conjugated to beads, as previously described (Lawrenson
et al., 2002). Western blotting was performed using anti-ADAM10
(Biogenesis, UK), anti-ephrin-A5 (R&D Systems), anti-HA (Roche),
and anti-EphA3 (Lackmann et al., 1998) antibodies.
Details of the production of Alexa-labeled ephrin-A5-Fc beads
and confocal microscopy on an Olympus FluoView 1000 micro-
scope equipped with HeCd (442 nm), Ar-ion (488 nm), HeNe (543
nm) and HeNe (633 nm) lasers were described previously (Wimmer-
Kleikamp et al., 2004). To monitor ADAM10-mediated cleavage dur-
ing cell-cell interactions, ephrin-expressing/HEK293 cells were in-
cubated (30–40 min) on a semiconfluent monolayer of EphA3/
HEK293 cells, transfected as described in the text. Following aspi-
ration of nonadherent cells, remaining cells were analyzed for
EphA3 expression using the anti-EphA3 IIIA4 monoclonal antibody,
reacting only with nondenatured EphA3 (Smith et al., 2004). Ephrin-
A5 and ADAM10 were detected, following fixation of cells (4% par-
formaldehyde), using rat anti-HA (Roche), goat anti-ephrin-A5, or
mouse anti-ADAM10 (R&D Systems) antibodies and appropriate
Alexa-labeled secondary antibodies. During confocal microscopy,
images of GFP/Alexa488, HcRed/Alexa546, and Alexa647 were col-
lected sequentially to minimize bleed-through from spectral over-
lap. Confocal images were processed using analySIS (Soft Imaging
System, Germany) and assembled into figures using Corel draw.
In Vitro Binding Assay
In “pull-down” experiments, ADAM10D+C, ADAM10D+C[EEE-A],
ADAM disintegrin domain (w15 g each) or ADAM cysteine-rich
domain (8 g) were incubated (4°C, 30 min) with Fc-tagged Eph or
ephrin ectodomains (R&D systems) in 10mM HEPES (pH 7.4),
150mM NaCl, 0.05% Triton X-100. Protein-A-Sepharose bound pro-
tein mixtures were washed with binding buffer and analyzed by
SDS-PAGE (10%–20% gradient).
Crystallization, Data Collection, and Structure Determination
ADAM10D+C was concentrated to 24 mg/ml in a buffer containing
10 mM HEPES (pH 7.4) and 150 mM NaCl. The protein was crystal-
lized in a hanging drop by vapor diffusion at room temperature
against a reservoir containing 0.2 M ammonium sulfate and 30%
polyethylene glycol 4000 (Hampton Research). Sizable crystals
(I4132 space group) grew after 2 months, but could be reproduced
in 2 to 3 days with streak seeding. For heavy-metal derivatization,
crystals were soaked in mother liquor containing 1 mM auric chlo-
ride and frozen with 20% glycerol as cryoprotectant.
The structure was determined by MAD phasing. The crystallo-
graphic data were collected on an ADSC Quantum 210 CCD detec-
tor at CHESS line F2. Oscillation photographs were integrated,
merged, and scaled using DENZO and SCALEPACK (Otwinowski
and Minor, 1997). Subsequent calculations were done with au-
toSHARP and the CCP4 program suite (CCP4, 1994). autoSHARP
was used to identify the location of two distinct gold atoms, as well
as to refine their position and occupancy for phase calculations.
Density modification with DM improved the two wavelength
(“peak” and “remote”) gold-derivative MAD maps that proved to be
of sufficient quality to trace the main chain unambiguously. Refine-
ment proceeded with iterative rounds of model adjustments, mo-
lecular dynamics, and energy minimization in CNS (Brunger et al.,
1998). The final model is refined at 2.9 Å resolution to R and free R
values of 26.1% and 28.9%, respectively. No electron density is
observed for the 28 N-terminal residues of the expression con-
struct, for residues 486–495 in the disintegrin domain, as well as for
residues 584–590 in the Cys-rich domain that are part of a surface-
exposed loop. Stereochemical analysis of the refined model using
PROCHECK (CCP4, 1994) revealed main chain and side chain
parameters better than or within the typical range of values for
protein structures determined at a corresponding resolution.Supplemental Data
Supplemental Data include one table and five figures and can be
found with this article online at http://www/cell.com/cgi/content/
full/123/2/291/DC1/.
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